doi:10.19982/j.issn.1000-6621.20250443

Abstract

CLC Number:

Figures/Tables 1

References 24

[1]	中华医学会结核病学分会. 非结核分枝杆菌病诊断与治疗指南(2020年版). 中华结核和呼吸杂志, 2020, 43(11):918-946. doi:10.3760/cma.j.cn112147-20200508-00570.
[2]	Trauth J, Discher T, Fritzenwanker M, et al. Hodgkin Lymphoma after Disseminated Mycobacterium genavense Infection, Germany. Emerg Infect Dis, 2022, 28(7):1506-1509. doi:10.3201/eid2807.220425.
[3]	戴维·吉尔伯特, 亨利·钱伯斯, 迈克尔·萨格, 等. 热病:桑福德抗微生物治疗指南. 53版. 范洪伟主译. 北京: 中国协和医科大学出版社, 2024.
[4]	Lange C, Böttger EC, Cambau E, et al. Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases. Lancet Infect Dis, 2022, 22(7): e178-e190. doi:10.1016/S1473-3099(21)00586-7.
[5]	首都医科大学附属北京胸科医院, 中国防痨协会非结核分枝杆菌分会, 《中国防痨杂志》编辑委员会. 非结核分枝杆菌病治疗药品超说明书用法专家共识. 中国防痨杂志, 2020, 42(8):769-787. doi:10.3969/j.issn.1000-6621.2020.08.002.
[6]	中华医学会感染病学分会艾滋病学组, 中国疾病预防控制中心,. 中国艾滋病诊疗指南(2024版). 中华传染病杂志, 2024, 42(1): 1-22. doi:10.3760/cma.j.cn311365-20240328-00081.
[7]	Hillebrand-Haverkort ME, Kolk AH, Kox LF, et al. Genera-lized Mycobacterium genavense infection in HIV-infected patients: detection of the mycobacterium in hospital tap water. Scand J Infect Dis, 1999, 31(1): 63-68. doi:10.1080/00365549950161907. pmid: 10381220
[8]	Bar-Oz M, Meir M, Barkan D. Virulence-Associated Secretion in Mycobacterium abscessus. Front Immunol, 2022, 13:938895. doi:10.3389/fimmu.2022.938895.
[9]	聂琦, 周勇, 陈华, 等. 非结核分枝杆菌病流行病学研究进展. 中华临床感染病杂志, 2020, 13(5): 394-400. doi:10.3760/cma.j.issn.1674-2397.2020.05.014.
[10]	段鸿飞. 非结核分枝杆菌病诊治六十年. 中国防痨杂志, 2024, 46(8):863-868. doi:10.19982/j.issn.1000-6621.20240114.
[11]	李昕洁, 谭守勇, 黄业伦, 等. 812株非结核分枝杆菌临床分离株流行病学特征分析. 中国防痨杂志, 2010, 32(12):811-814.
[12]	Kaewseekhao B, Nuntawong N, Eiamchai P, et al. Diagnosis of active tuberculosis and latent tuberculosis infection based on Raman spectroscopy and Surface-enhanced Raman Spectroscopy. Tuberculosis (Edinb), 2020, 121: 101916. doi:10.1016/j.tube.2020.101916.
[13]	Montelongo-Jauregui D, McFarland J, Pham J, et al. The Brief Case: Complexity of laboratory diagnosis of Mycobacterium genavense-a classic case of an unusual pathogen. J Clin Microbiol, 2025, 63(4):e0146324. doi:10.1128/jcm.01463-24.
[14]	中国防痨协会非结核分枝杆菌病分会. 非结核分枝杆菌病分子生物学诊断专家共识. 中国防痨杂志, 2025, 47(8):961-975. doi:10.19982/j.issn.1000-6621.20250225.
[15]	Álvaro-Meca A, Rodríguez-Gijón L, Díaz A, et al. Trends in nontuberculous mycobacterial disease in hospitalized subjects in Spain (1997—2010) according to HlV infection. HIV Med, 2015, 16(8):485-493. doi:10.1111/hiv.12251.
[16]	王美霁, 李锋. 脂阿拉伯甘露聚糖抗原检测用于艾滋病病毒感染者和艾滋病患者结核病诊断的研究进展. 中华结核和呼吸杂志, 2024, 47(5):475-480. doi:10.3760/cma.j.cn112147-20231114-00310.
[17]	Marino S, Cilfone NA, Mattila JT, et al. Macrophage polariza-tion drives granuloma outcome during Mycobacterium tuberculosis infection. Infect Immun, 2015, 83(1):324-328. doi:10.1128/IAI.02494-14.
[18]	Wetzstein N, Kessel J, Bingold TM. High Overall Mortality of Mycobacterium genavense Infections and Impact of Antimycobacterial Therapy: Systematic Review and Individual Patient Data meta-analysis. J Infect, 2022, 84(1):8-16. doi:10.1016/j.jinf.2021.10.027.
[19]	张卉, 葛莉, 张煜涵, 等. 34例非结核分枝杆菌病的临床病理特征分析. 中国防痨杂志, 2024, 46(7):756-762. doi:10.19982/j.issn.1000-6621.20240151.
[20]	刘盛盛, 唐神结. 《非结核分枝杆菌病诊断与治疗指南(2020年版)》解读. 结核与肺部疾病杂志, 2021, 2(2):108-115. doi:10.3969/j.issn.2096-8493.2021.02.004.
[21]	季原飞, 于霞, 王珏, 等. 鸟-胞内分枝杆菌肺病患者CT影像学特征及其在非结核分枝杆菌肺病中的诊断价值. 中国防痨杂志, 2026, 48(2): 256-263. doi:10.19982/j.issn.1000-6621.20250417.
[22]	王飞, 华朵, 郭建建, 等. 2021—2023年武汉地区非结核分枝杆菌肺病患者特征分析. 中国防痨杂志, 2024, 46(9):1069-1076. doi:10.19982/j.issn.1000-6621.20240179.
[23]	孟涵, 王洪武. 硬质支气管镜的现代临床应用. 国际呼吸杂志, 2023, 43(3):361-364. doi:10.3760/cma.j.cn131368-20221115-01036.
[24]	张杰. 良性气道疾病呼吸介入操作的规范性要求. 中华结核和呼吸杂志, 2023, 46(10): 1038-1043. doi:10.3760/cma.j.cn112147-20230623-00332.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 24

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Li Qin, Li Linhong, Liu Jiao, Feng Mei, Xie Qi, Zhang Guixian, Yang Qiong, Yang Dandan. A case of AIDS with rifampicin-resistant tuberculous breast abscess and literature review [J]. Chinese Journal of Antituberculosis, 2026, 48(5): 687-693.
[2]	Ji Yuanfei, Yu Xia, Wang Jue, Sun Mengyan, He Wei, Lyu Yan, Hou Dailun, Li Chenghai. The CT imaging features of Mycobacterium avium-intracellulare pneumonia and the diagnostic evaluation of in non-tuberculous mycobacterium pneumonia [J]. Chinese Journal of Antituberculosis, 2026, 48(2): 256-263.
[3]	. [J]. Chinese Journal of Antituberculosis, 2026, 48(1): 160-163.
[4]	Nontuberculous Mycobacterial Diseases Branch of Chinese Antituberculosis Association. Expert consensus on molecular biology diagnosis of nontuberculous mycobacteria diseases [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 961-975.
[5]	Wang Jing, Wang Qingfeng, Jing Wei, Wang Yujin, Wang Xueyu, Huang Hairong, Chu Naihui, Nie Wenjuan. Dosage of recombinant Mycobacterium tuberculosis fusion protein for skin testing in the 18-65 year-old population and its safety in the 3-17 and 66-75 year-old populations: a randomized, blinded, positive-controlled phase Ⅱ clinical trial [J]. Chinese Journal of Antituberculosis, 2025, 47(7): 840-845.
[6]	Li Longfen, Shi Chunjing, Luo Yun, Zhang Huajie, Liu Jun, Wang Ge, Zhao Yanhong, Yuan Lijuan, Li Shan, Li Wenming, Shen Lingjun. Establishing and validating a prediction model for HIV-associated nontuberculous mycobacterial disease based on machine learning [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 708-718.
[7]	Gu Yuzhen, Chen Siyi, Huang Hairong, Yu Xia. Evaluation of in vitro activity of lefamulin against mycobacteria [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 732-737.
[8]	. [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 531-534.
[9]	Li Leilei, Shi Lei, Wang Lin, Li Hongwei, Xu Liran, Pang Yu, Song Yanzheng. Clinical characteristics analysis of HIV-infected cases diagnosed with tuberculosis after surgery due to pulmonary nodules [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 266-273.
[10]	Zhang Guoqin, Qu Ting, Meng Qinglin, Zhou Lin, Liu Eryong. Implementation update of strategy for the control of tuberculosis and HIV/AIDS co-infection in China [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 12-17.
[11]	Expert Consensus on the Diagnosis and Treatment of Spinal Tuberculosis Combined with HIV/AIDS Patients Group, Combined with HIV/AIDS Patients Group Chinese Antituberculosis Association, Chinese Antituberculosis Association of STD and AIDS Prevention and Control, the Western China Bone Tuberculosis Alliance, the North China Bone the North China Bone. Expert consensus on diagnosis and treatment of spinal tuberculosis with HIV/AIDS (2nd Edition) [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 1-11.
[12]	. [J]. Chinese Journal of Antituberculosis, 2024, 46(11): 1414-1417.
[13]	Li Xiang, Pu Ying, Fu Xuwen, Qi Min, Wei Jialu, Cun Xinhua. Clinical and imaging characterization of fungal spondylitis misdiagnosed as spinal tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1109-1114.
[14]	Wang Yilin, Wu Xiao, Pang Yu, Li Shanshan. Immunomodulatory effect of orelabrutinib in host macrophages infected with mycobacterium [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1063-1068.
[15]	Li Zhili, Liu Yuhong. Interpretation of WHO consolidated guidelines on tuberculosis. Module 6: tuberculosis and comorbidities-HIV [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 869-873.